Trials / Completed
CompletedNCT00259038
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
A Phase II, Dose Escalation Evaluation of the Pharmacokinetic and Hemodynamic Effects of Carperitide in Subjects With Congestive Heart Failure
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 162 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study will evaluate the safety and efficacy of intravenous infusion of carperitide using pressure measurements inside the heart and great vessels and measuring carperitide concentration in the blood.
Conditions
- Heart Failure, Congestive
- Heart Decompensation
- Left Ventricular Failure
- Myocardiopathies
- Systolic or Diastolic Left Ventricular Dysfunction
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carperitide | |
| DRUG | Placebo |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2006-02-01
- Completion
- 2006-02-01
- First posted
- 2005-11-29
- Last updated
- 2016-11-08
Locations
34 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00259038. Inclusion in this directory is not an endorsement.